Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

South Africa study suggests Omicron could displace Delta

Published 28/12/2021, 07:31
Updated 28/12/2021, 09:15
© Reuters. A vial and a syringe are seen in front of a displayed South Africa flag and words "Omicron SARS-CoV-2" in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) - Research by South African scientists suggests that Omicron could displace the Delta variant of the coronavirus because infection with the new variant boosts immunity to the older one.

The study only covered a small group of people and has not been peer-reviewed, but it found that people who were infected with Omicron, especially those who were vaccinated, developed enhanced immunity to the Delta variant.

The analysis enrolled 33 vaccinated and unvaccinated people who were infected with the Omicron variant in South Africa.

While the authors found that neutralisation of Omicron increased 14-fold over 14 days after the enrolment, they also found that there was a 4.4-fold increase in neutralisation of the Delta variant.

"The increase in Delta variant neutralization in individuals infected with Omicron may result in decreased ability of Delta to re-infect those individuals," the scientists who conducted the study said.

The results of the study are "consistent with Omicron displacing the Delta variant, since it can elicit immunity which neutralizes Delta making re-infection with Delta less likely," they said.

According to the scientists, implications of this displacement would depend on whether or not Omicron is less pathogenic compared to Delta. "If so, then the incidence of COVID-19 severe disease would be reduced and the infection may shift to become less disruptive to individuals and society."

Alex Sigal, a professor at the Africa Health Research Institute in South Africa, said on Twitter (NYSE:TWTR) on Monday that if Omicron was less pathogenic as it looked to be from the South African experience, "this will help push Delta out".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

According to an earlier South African study, there is reduced risk of hospitalisation and severe disease in people infected with Omicron compared with the Delta variant, though the authors say some of that is likely due to high population immunity.

The Omicron variant, first detected in southern Africa and Hong Kong in November, has since spread worldwide and threatened to overwhelm hospitals in some countries.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.